Answers are grounded in this paper and cite their sources.
We describe a fatal case of invasive pulmonary aspergillosis in a patient with rheumatoid arthritis receiving the TNF-α inhibitor, adalimumab. The use of TNF-α inhibitor has been associated with an increased risk of infections, including tuberculosis and other opportunistic infections. Physicians should have a high index of suspi-cion for opportunistic infection that can develop during TNF-α inhibitor treatment.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: